Role of the orphan nuclear receptor ROR alpha in the control of the metastatic behavior of androgen-independent prostate cancer cells.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Oncology Report

• Publication date

  2002-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/OR.9.5.1139PMID 12168086
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Melatonin and RZR/ROR receptor ligand CGP 52608 induce apoptosis in the murine colonic cancer

  2001cited by this paper
• Oncostatic activity of a thiazolidinedione derivative on human androgen‐dependent prostate cancer cells

  2001cited by this paper
• Activation of the orphan nuclear receptor RORalpha induces growth arrest in androgen-independent DU 145 prostate cancer cells.

  2001cited by this paper
• Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines

  2000cited by this paper
• Gene Regulation by Melatonin

  2000cited by this paper
• In vitro and in vivo evidence for orphan nuclear receptor RORalpha function in bone metabolism.

  2000cited by this paper
• Prostatic carcinoma cell migration via alpha(v)beta3 integrin is modulated by a focal adhesion kinase pathway.

  1999cited by this paper
• Orphan nuclear receptors: from gene to function.

  1999cited by this paper
• The oncostatic action of melatonin in an ovarian carcinoma cell line

  1999cited by this paper
• Exogenous expression of a dominant negative RORalpha1 vector in muscle cells impairs differentiation: RORalpha1 directly interacts with p300 and myoD.

  1999cited by this paper
• Cancer statistics, 1999

  1999cited by this paper
• staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice.

  1998cited by this paper
• Specific activation of the nuclear receptors PPARgamma and RORA by the antidiabetic thiazolidinedione BRL 49653 and the antiarthritic thiazolidinedione derivative CGP 52608.

  1998cited by this paper
• Transcriptional regulation of a Purkinje cell‐specific gene through a functional interaction between RORα and RAR

  1997cited by this paper
• Melatonin enhances IL-2, IL-6, and IFN-gamma production by human circulating CD4+ cells: a possible nuclear receptor-mediated mechanism involving T helper type 1 lymphocytes and monocytes.

  1997cited by this paper
• Molecular markers for prostate cancer metastasis. Developing diagnostic methods for predicting the aggressiveness of prostate cancer.

  1997cited by this paper
• Affinity of Antibodies to MUC1 Antigens

  1997cited by this paper
• Prostate cancer: a clinical and basic science review.

  1997cited by this paper
• Cleavage of beta 4 integrin by matrilysin.

  1997cited by this paper
• Transcriptional Regulation of Apolipoprotein A-I Gene Expression by the Nuclear Receptor RORα*

  1997cited by this paper
• The metastasis suppressor candidate nucleotide diphosphate kinase NM23 specifically interacts with members of the ROR/RZR nuclear orphan receptor subfamily.

  1996cited by this paper
• Identification of Natural Monomeric Response Elements of the Nuclear Receptor RZR/ROR. THEY ALSO BIND COUP-TF HOMODIMERS*

  1996cited by this paper
• Thiazolidine Diones, Specific Ligands of the Nuclear Receptor Retinoid Z Receptor/Retinoid Acid Receptor-related Orphan Receptor α with Potent Antiarthritic Activity*

  1996cited by this paper
• Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand.

  1995cited by this paper
• Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors.

  1994cited by this paper
• RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers.

  1994cited by this paper
• The cellular basis for prostate cancer metastasis.

  1992cited by this paper
• Integrins and metastases: an overview.

  1991cited by this paper
• Carcinoma of the prostate.

  1991cited by this paper
• Isolation of a human prostate carcinoma cell line (DU 145)

  1978cited by this paper

• Arrhythmic expression signatures of circadian clock‐associated transcription factors and chronic circadian disruption contribute to advanced prostate cancer growth

  2025cites this paper
• Stage-dependent EZH2 methylation correlates with immune polarization, metabolic suppression, and unfavorable outcomes in hepatocellular carcinoma

  2025cites this paper
• Targeting EZH2 in Cancer: Mechanisms, Pathways, and Therapeutic Potential

  2024cites this paper
• ROS inhibits RORα degradation by decreasing its arginine methylation in liver cancer

  2022cites this paper
• Hsa‐miR‐1290 is associated with stemness and invasiveness in prostate cancer cell lines by targeting RORA

  2022cites this paper
• Orphan receptors in prostate cancer

  2022cites this paper
• Epigenetic Regulation in Breast Cancer.

  2021cites this paper
• Isoform-Specific Lysine Methylation of RORα2 by SETD7 Is Required for Association of the TIP60 Coactivator Complex in Prostate Cancer Progression

  2020cites this paper
• Nongenomic Actions of Thyroid Hormone: the Integrin Component.

  2020cites this paper
• ROR-α-1 inhibits the proliferation, invasion, and migration of hepatocellular carcinoma MHCC97H via downregulation of chemokine CXCL5.

  2020cites this paper
• Ellagic Acid, Kaempferol, and Quercetin from Acacia nilotica: Promising Combined Drug With Multiple Mechanisms of Action

  2019cites this paper
• The Role of Nuclear Receptors in Prostate Cancer

  2019cites this paper
• RORα Suppresses Epithelial-to-Mesenchymal Transition and Invasion in Human Gastric Cancer Cells via the Wnt/β-Catenin Pathway

  2019cites this paper
• Genetic variants in RORA and DNMT1 associated with cutaneous melanoma survival

  2018cites this paper
• The effect of RORa expression on the development of biological malignancy of urinary bladder cancer

  2018cites this paper
• WOMEN IN CANCER THEMATIC REVIEW: New roles for nuclear receptors in prostate cancer.

  2016cites this paper
• AWARD NUMBER: W81XWH-14-1-0153 TITLE: Identification of Novel Drug Targets and Lead Compounds for Advanced Prostate Cancer through Genomic and Cheminformatic Analyses PRINCIPAL INVESTIGATOR: Dr. Michael Hsing CONTRACTING ORGANIZATION: UNIVERSITY OF BRITISH COLUMBIA

  2016cites this paper
• EZH2 in Bladder Cancer, a Promising Therapeutic Target

  2015cites this paper
• Identification of Novel Drug Targets and Lead Compounds for 5 a . CONTRACT NUMBER Advanced Prostate Cancer through Genomic and Cheminformatic Analyses

  2015cites this paper
• Orphan nuclear receptors as drug targets for the treatment of prostate and breast cancers.

  2014cites this paper
• Emerging roles of orphan nuclear receptors in cancer.

  2014cites this paper
• Distinct nuclear receptor expression in stroma adjacent to breast tumors

  2013cites this paper
• EZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex.

  2012cites this paper
• Altered expression of NFY-C and RORA in colorectal adenocarcinomas.

  2012cites this paper
• Combined targeting of the VEGFr/EGFr and the mammalian target of rapamycin (mTOR) signaling pathway delays cell cycle progression and alters adhesion behavior of prostate carcinoma cells.

  2011cites this paper
• Association between Prostinogen (KLK15) Genetic Variants and Prostate Cancer Risk and Aggressiveness in Australia and a Meta-Analysis of GWAS Data

  2011cites this paper
• The Molecular Genetics of Autism Spectrum Disorders: Genomic Mechanisms, Neuroimmunopathology, and Clinical Implications

  2011cites this paper
• Étude de l'impact des récepteurs non stéroïdiens sur l'activité androgénique dans les cellules cancéreuses de la prostate

  2008cites this paper
• Gonadotropin-releasing hormone agonists reduce the migratory and the invasive behavior of androgen-independent prostate cancer cells by interfering with the activity of IGF-I.

  2007cites this paper
• Marelli 8_9

  2006cites this paper
• Insulin-like growth factor-I promotes migration in human androgen-independent prostate cancer cells via the alphavbeta3 integrin and PI3-K/Akt signaling.

  2006cites this paper
• Cell Motility in Prostate Tumor Invasion and Metastasis

  2006cites this paper
• Activation of the orphan nuclear receptor RORα counteracts the proliferative effect of fatty acids on prostate cancer cells: Crucial role of 5‐lipoxygenase

  2004cites this paper